Alector, Inc. (ALEC) vs X4 Pharmaceuticals, Inc. (XFOR)
- Alector, Inc. ALEC 2.30 +10.05%
- X4 Pharmaceuticals, Inc. XFOR 3.15 +2.61%
Alector, Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Alector, Inc. and X4 Pharmaceuticals, Inc. are of similar size ($309.9M and $304.4M). X4 Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 6.6×. Alector, Inc. grew revenue faster over the last twelve months: 151.2% against −50.1%. Alector, Inc. has the higher net margin (23.9% vs −474.7%) and the higher return on invested capital (0.00% vs −178.2%). Across the 17 metrics below, Alector, Inc. leads on 14 and X4 Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ALEC | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 81.77% | 68.51% |
| Operating margin | 20.16% | (473.95%) | 0.00% |
| Net margin | 23.87% | (474.74%) | 0.00% |
| Free cash flow margin | (86.40%) | (478.16%) | 0.00% |
| Return on equity | 47.52% | (80.32%) | (51.96%) |
| Return on assets | 16.53% | (40.73%) | (46.06%) |
| Return on invested capital | 0.00% | (178.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack